ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Loss of VMP1 Impairs Tight Junction Recycling and Aggravates Intestinal Barrier Dysfunction in Inflammatory Bowel Disease.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Phenyllactic Acid Restores Intestinal Epithelial Barrier to Alleviate Hypertriglyceridemic Acute Pancreatitis via a PPARγ-Dependent Mechanism.Antioxidants (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Inflammatory bowel disease (IBD) is a chronic and relapsing inflammatory disorder of the gastrointestinal tract. This disease is characterized by a steadily increasing global incidence. Multiple susceptibility genes are implicated in IBD pathogenesis. However, the molecular mechanisms linking epithelial barrier dysfunction to disease progression remain poorly understood. This study performs an integrative analysis of public bulk RNA-seq and single-cell transcriptomic datasets. Experimental validation is conducted using clinical samples. Analyses reveal that vacuole membrane protein 1 (VMP1) is significantly downregulated in IBD. This reduced expression correlates with disease severity. Functional studies demonstrate that VMP1 deficiency in intestinal epithelial cells disrupts tight junction integrity. This loss increases epithelial permeability and exacerbates intestinal inflammation. Mechanistically, VMP1 facilitates the recruitment of CORO1C to late endosomes. This recruitment promotes Retromer-mediated recycling of the tight junction protein Occludin to the plasma membrane. Impairment of this pathway shifts Occludin trafficking toward ESCRT-dependent microautophagic degradation. This shift results in the sustained loss of tight junctions. These findings identify VMP1 as a previously unrecognized regulator of epithelial tight junction recycling and barrier homeostasis. This discovery provides new mechanistic insights into IBD pathogenesis and highlights a promising therapeutic avenue for restoring intestinal barrier function.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.